Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_assertion type Assertion NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_head.
- NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_assertion description "[The scenarios involve glutathione-S-transferase theta 1 (GSTT1) and hematopoietic cancer in hospital workers, human leukocyte antigen coding for glutamic acid in the 69th position (HLA DPB1(E69)) and chronic beryllium disease in beryllium workers, and peripheral myelin protein 22 (PMP22) deletion and carpal tunnel syndrome in railroad track workers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_provenance.
- NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_assertion evidence source_evidence_literature NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_provenance.
- NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_assertion SIO_000772 15018031 NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_provenance.
- NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_assertion wasDerivedFrom befree-20150227 NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_provenance.
- NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_assertion wasGeneratedBy ECO_0000203 NP440807.RA_lapk4g9VP_wN2QtN8OUxTuRnWultQqSCn5CxNGRseM130_provenance.